Electrophysiological analysis of a murine model of motoneuron disease

Clinical Neurophysiology

Volumn 122, Issue 8, 2011, Pages 1660-1670

  Mancuso, Renzo ^a   Santos Nogueira, Eva ^a   Osta, Rosario ^b   Navarro, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Electrophysiology; Motoneuron disease; Motor unit; Nerve conduction; Neurodegeneration

Indexed keywords

ANIMAL MODEL; ARTICLE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; HINDLIMB; HOFFMANN REFLEX; MOTOR NERVE CONDUCTION; MOTOR NEURON DISEASE; MOUSE; MUSCLE INNERVATION; NERVE CONDUCTION; NONHUMAN; PATIENT MONITORING; PLANTARIS MUSCLE; PRIORITY JOURNAL; ROTAROD TEST; SPINAL CORD MOTONEURON; TIBIALIS ANTERIOR MUSCLE; TRANSGENIC MOUSE; WILD TYPE;

EID: 79960231921     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.01.045     Document Type: Article

References (46)

1. Arasaki K., Tamaki M., Hosoya Y., Kudo N. Validity of electromyograms and tension as a means of motor unit number estimation. Muscle Nerve 1997, 20:552-560.
2. Azzouz M., Leclerc N., Gurney M., Warter J.M., Poindron P., Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve 1997, 20:45-51.
3. Boërio D., Kalmar B., Greensmith L., Bostock H. Excitability properties of mouse motor axons in the mutant SOD1(G93A) model of amyotrophic lateral sclerosis. Muscle Nerve 2010.
4. Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 2010, 13:1396-1403.
5. Brown R.H. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995, 80:687-692.
6. Bruna J., Udina E., Ale A., Vilches J.J., Vynckier A., Monbaliu J., et al. Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice. Exp Neurol 2010, 223:599-608.
7. Chang Q., Martin L.J. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice. a quantitative confocal analysis. Am J Pathol 2009, 174:574-585.
8. de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 119:497-503.
9. Dengler R., Konstanzer A., Kuther G., Hesse S., Wolf W., Struppler A. Amyotrophic lateral sclerosis: macro-EMG and twitch forces of single motor units. Muscle Nerve 1990, 13:545-550.
10. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004, 185:232-240.
11. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 2000, 20:2534-2542.
12. Garcia-Alias G., Verdu E., Fores J., Lopez-Vales R., Navarro X. Functional and electrophysiological characterization of photochemical graded spinal cord injury in the rat. J Neurotrauma 2003, 20:501-510.
13. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
14. Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2007, 28:154-164.
15. Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol (Lond) 2008, 586:3337-3351.
16. Iwata N.K. Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis. Brain Nerve 2007, 59:1053-1064.
17. Kennel P.F., Fonteneau P., Martin E., Schmidt J.M., Azzouz M., Borg J., et al. Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiol Dis 1996, 3:137-147.
18. Kraemer M., Buerger M., Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2010, 112:103-105.
19. Krarup C. Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis. Clinical Neurophysiol 2011, 122:414-422.
20. Kuo J.J., Schonewille M., Siddique T., Schults A.N.A., Fu R., Bär P.R., et al. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J Neurophysiol 2004, 91:571-575.
21. Lago N., Udina E., Ramachandran A., Navarro X. Neurobiological assessment of regenerative electrodes for bidirectional interfacing injured peripheral nerves. IEEE Trans Biomed Eng 2007, 54:1129-1137.
22. Leigh P.N., Ray-Chaudhuri K. Motor neuron disease. J Neurol Neurosurg Psychiatry 1994, 57:886-896.
23. Ludolph A.C., Jesse S. Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials. Ther Adv Neurol Disord 2009, 2:319-326.
24. McHanwell S., Biscoe T.J. The localization of motoneurons supplying the hindlimb muscles of the mouse. Philos Trans R Soc London B Biol Sci 1981, 293:477-508.
25. Miana-Mena F.J., Muñoz M.J., Yagüe G., Mendez M., Moreno M., Ciriza J., et al. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:55-62.
26. Mitsumoto H., Ulug A.M., Pullman S.L., Gooch C.L., Chan S., Tang M.-X., et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007, 68:1402-1410.
27. Moreno-Igoa M., Calvo A.C., Penas C., Manzano R., Oliván S., Muñoz M.J., et al. Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy. J Mol Med 2010, 88:297-308.
28. Navarro X., Udina E. Chapter 6 - Methods and Protocols in Peripheral Nerve Regeneration Experimental Research: Part III-Electrophysiological Evaluation. Int Rev Neurobiol 2009, 87:105-126.
29. Navarro X., Verdu E., Buti M. Comparison of regenerative and reinnervating capabilities of different functional types of nerve fibers. Exp Neurol 1994, 129:217-224.
30. Penas C., Casas C., Robert I., Fores J., Navarro X. Cytoskeletal and activity-related changes in spinal motoneurons after root avulsion. J Neurotrauma 2009, 26:763-779.
31. Pun S., Santos A.F., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 2006, 9:408-419.
32. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995, 92:689-693.
33. Shefner J.M., Cudkowicz M., Brown R.H. Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2006, 34:603-607.
34. Shefner J.M., Cudkowicz M.E., Brown R.H. Comparison of incremental with multipoint MUNE methods in transgenic ALS mice. Muscle Nerve 2002, 25:39-42.
35. Shefner J.M., Reaume A.G., Flood D.G., Scott R.W., Kowall N.W., Ferrante R.J., et al. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 1999, 53:1239-1246.
36. Sobue G., Sahashi K., Takahashi A., Matsuoka Y., Muroga T., Sobue I. Degenerating compartment and functioning compartment of motor neurons in ALS: possible process of motor neuron loss. Neurology 1983, 33:654-657.
37. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Progr Neurobiol 2008, 85:94-134.
38. Udina E., Ceballos D., Gold B.G., Navarro X. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp Neurol 2003, 183:220-231.
39. Valero-Cabré A., Navarro X. H reflex restitution and facilitation after different types of peripheral nerve injury and repair. Brain Res 2001, 919:302-312.
40. Verdú E., Vilches J.J., Rodriguez F.J., Ceballos D., Valero A., Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve 1999, 22:329-340.
41. Wada N., Yawashima Y., Nakajima Y. Effect of nucleus raphe magnus stimulation on recurrent inhibition of the monosynaptic reflex in the cat. Neurosci Lett 1989, 107:94-98.
42. Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009, 4:3.
43. Wegorzewska I., Bell S., Cairns N., Miller T., Baloh R. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 2009, 106:18809-18814.
44. Worms P.M. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001, 191:3-9.
45. Zang D.W., Cheema S.S. Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1(G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 2002, 332:99-102.
46. Zona C., Pieri M., Carunchio I. Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis. J Neurophysiol 2006, 96:3314-3322.